Sarah Church, a clinical psychologist and executive director of Wholeview Wellness in New York City, said more robust studies are needed
"It is critical for us to get the results of a randomized controlled trial that compares GLP-1s to the other FDA-approved medications for (alcohol addiction) before we jump to conclusions about the relative effectiveness of the different medications," Church said.
Read More